VirtuS-Investment-Advisers

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
473
Total Value
367795360
Accession Number
0000019481-25-000015
Form Type
13F-HR
Manager Name
VirtuS-Investment-Advisers
Data Enrichment
95% identified
447 identified26 unidentified

Holdings

473 positions • $367.8M total value
Manager:
Search and click to pin securities to the top
Page 13 of 24
Roivant Sciences Ltd.
Shares:30.2K
Value:$304.9K
% of Portfolio:0.1% ($304.9K/$367.8M)
Aurinia Pharmaceuticals Inc.
Shares:37.1K
Value:$297.9K
% of Portfolio:0.1% ($297.9K/$367.8M)
IONIS PHARMACEUTICALS INC
Shares:9.7K
Value:$292.7K
% of Portfolio:0.1% ($292.7K/$367.8M)
AMICUS THERAPEUTICS, INC.
Shares:35.4K
Value:$288.6K
% of Portfolio:0.1% ($288.6K/$367.8M)
Phathom Pharmaceuticals, Inc.
Shares:45.0K
Value:$281.9K
% of Portfolio:0.1% ($281.9K/$367.8M)
Ultragenyx Pharmaceutical Inc.
Shares:7.7K
Value:$277.2K
% of Portfolio:0.1% ($277.2K/$367.8M)
AGIOS PHARMACEUTICALS, INC.
Shares:9.4K
Value:$275.7K
% of Portfolio:0.1% ($275.7K/$367.8M)
BioNTech SE
Shares:3.0K
Value:$271.0K
% of Portfolio:0.1% ($271.0K/$367.8M)
CRISPR Therapeutics AG
Shares:7.9K
Value:$269.0K
% of Portfolio:0.1% ($269.0K/$367.8M)
Xeris Biopharma Holdings, Inc.
Shares:48.3K
Value:$265.1K
% of Portfolio:0.1% ($265.1K/$367.8M)
NOVAVAX INC
Shares:39.8K
Value:$255.2K
% of Portfolio:0.1% ($255.2K/$367.8M)
SOLENO THERAPEUTICS INC
Shares:3.5K
Value:$253.1K
% of Portfolio:0.1% ($253.1K/$367.8M)
Apellis Pharmaceuticals, Inc.
Shares:11.0K
Value:$239.8K
% of Portfolio:0.1% ($239.8K/$367.8M)
Moderna, Inc.
Shares:8.4K
Value:$237.7K
% of Portfolio:0.1% ($237.7K/$367.8M)
Akero Therapeutics, Inc.
Shares:5.7K
Value:$228.9K
% of Portfolio:0.1% ($228.9K/$367.8M)
Day One Biopharmaceuticals, Inc.
Shares:28.0K
Value:$222.3K
% of Portfolio:0.1% ($222.3K/$367.8M)
Liquidia Corp
Shares:14.9K
Value:$219.9K
% of Portfolio:0.1% ($219.9K/$367.8M)
Mineralys Therapeutics, Inc.
Shares:13.5K
Value:$214.3K
% of Portfolio:0.1% ($214.3K/$367.8M)
Veren Inc.
Shares:32.2K
Value:$212.9K
% of Portfolio:0.1% ($212.9K/$367.8M)
Arcutis Biotherapeutics, Inc.
Shares:13.4K
Value:$209.6K
% of Portfolio:0.1% ($209.6K/$367.8M)